WO2009001617A1 - 透明ゲル状組成物及び透明ゲル状薬剤の製造方法 - Google Patents

透明ゲル状組成物及び透明ゲル状薬剤の製造方法 Download PDF

Info

Publication number
WO2009001617A1
WO2009001617A1 PCT/JP2008/058536 JP2008058536W WO2009001617A1 WO 2009001617 A1 WO2009001617 A1 WO 2009001617A1 JP 2008058536 W JP2008058536 W JP 2008058536W WO 2009001617 A1 WO2009001617 A1 WO 2009001617A1
Authority
WO
WIPO (PCT)
Prior art keywords
transparent gel
gel composition
drug
producing
gelling agent
Prior art date
Application number
PCT/JP2008/058536
Other languages
English (en)
French (fr)
Inventor
Naoyuki Narisada
Koutaro Mizoguchi
Original Assignee
S.T. Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S.T. Corporation filed Critical S.T. Corporation
Publication of WO2009001617A1 publication Critical patent/WO2009001617A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions
    • A61L9/012—Deodorant compositions characterised by being in a special form, e.g. gels, emulsions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Colloid Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

　透明度が高く、離水を生じることなく、また、被膜形成や細菌の繁殖によるゲルの破壊などの問題が生じにくい透明ゲル状組成物を提供することを目的とし、ゲル化剤、揮散性薬剤、界面活性剤及び水を含有する透明ゲル状組成物であって、ゲル化剤として乾燥物での窒素含有率が０.０１質量％以下、１００ｇ当たりのカルシウム含量が２５ｍｇ以下である精製κ―カラギーナンを含むものであることを特徴とする透明ゲル状組成物およびこれを利用する透明ゲル状薬剤の製造方法を提供する。
PCT/JP2008/058536 2007-06-22 2008-05-08 透明ゲル状組成物及び透明ゲル状薬剤の製造方法 WO2009001617A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007164856A JP5307362B2 (ja) 2007-06-22 2007-06-22 透明ゲル状組成物及び透明ゲル状薬剤の製造方法
JP2007-164856 2007-06-22

Publications (1)

Publication Number Publication Date
WO2009001617A1 true WO2009001617A1 (ja) 2008-12-31

Family

ID=40185440

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/058536 WO2009001617A1 (ja) 2007-06-22 2008-05-08 透明ゲル状組成物及び透明ゲル状薬剤の製造方法

Country Status (2)

Country Link
JP (1) JP5307362B2 (ja)
WO (1) WO2009001617A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5254572B2 (ja) * 2007-06-22 2013-08-07 エステー株式会社 精製カラギーナン及びその製造方法
JP5416641B2 (ja) * 2010-04-02 2014-02-12 花王株式会社 水性ゲル消臭芳香剤
JPWO2014119346A1 (ja) * 2013-01-30 2017-01-26 日本ゼオン株式会社 消臭剤及び繊維製品
JP6689052B2 (ja) * 2015-10-02 2020-04-28 帝人ファーマ株式会社 ２価カチオン低含有カラギーナン及びその製造方法
JP6759049B2 (ja) * 2016-10-24 2020-09-23 エステー株式会社 ゲル状組成物およびその製造法並びにゲル状組成物の収縮改善剤および収縮改善方法
WO2019087840A1 (ja) * 2017-10-31 2019-05-09 エステー株式会社 水系ゲル状組成物
JP6763100B1 (ja) 2019-08-23 2020-09-30 梨沙 西原 体液漏出防止剤

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6440542A (en) * 1987-08-06 1989-02-10 Kobayashi Pharma Clear gel composition
JPH10226749A (ja) * 1996-12-12 1998-08-25 Lion Corp 水性ゲル状組成物
JP2000288076A (ja) * 1999-04-07 2000-10-17 Lion Corp 芳香消臭剤組成物
JP2001279119A (ja) * 2000-03-30 2001-10-10 Shiseido Co Ltd ゲル状芳香剤組成物
JP2001327265A (ja) * 2000-05-22 2001-11-27 Sanei Gen Ffi Inc 牛肉加工品及び牛肉加工品の食感改善方法
JP2004254573A (ja) * 2003-02-25 2004-09-16 Sanei Gen Ffi Inc 多層状食品

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009001526A (ja) * 2007-06-22 2009-01-08 St Kk ゲル状薬剤及びその製造方法
JP5254572B2 (ja) * 2007-06-22 2013-08-07 エステー株式会社 精製カラギーナン及びその製造方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6440542A (en) * 1987-08-06 1989-02-10 Kobayashi Pharma Clear gel composition
JPH10226749A (ja) * 1996-12-12 1998-08-25 Lion Corp 水性ゲル状組成物
JP2000288076A (ja) * 1999-04-07 2000-10-17 Lion Corp 芳香消臭剤組成物
JP2001279119A (ja) * 2000-03-30 2001-10-10 Shiseido Co Ltd ゲル状芳香剤組成物
JP2001327265A (ja) * 2000-05-22 2001-11-27 Sanei Gen Ffi Inc 牛肉加工品及び牛肉加工品の食感改善方法
JP2004254573A (ja) * 2003-02-25 2004-09-16 Sanei Gen Ffi Inc 多層状食品

Also Published As

Publication number Publication date
JP5307362B2 (ja) 2013-10-02
JP2009001701A (ja) 2009-01-08

Similar Documents

Publication Publication Date Title
WO2009001617A1 (ja) 透明ゲル状組成物及び透明ゲル状薬剤の製造方法
WO2008077614A3 (de) Verwendung einer zusammensetzung aus mineralstoffen und gegebenenfalls acetogenen und/oder butyrogenen bakterien zur vermeidung oder reduzierung von gasbildung im dickdarm eines säugetiers und dadurch bedingter abdominaler beschwerden
WO2007143607A3 (en) Method of treating atrophic vaginitis
MX2011010324A (es) Tableta recubierta que se desintegra oralmente.
WO2008039737A3 (en) A method of administering a film product containing a drug
WO2008101723A3 (en) Pharmaceutical composition containing a cholesterol absorption inhibitor
ATE533476T1 (de) Komprimierte pharmazeutische zusammensetzung mit beschichteten pellets und direktes kompressionsgemisch und herstellungsverfahren dafür
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
MX2009006033A (es) Composiciones y articulos que contienen una matriz de polimero reticulado y un liquido activo inmovilizado, asi como metodos para fabricarlos.
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
PL1608346T3 (pl) Kompozycje dostarczające lek zawierające estry alfa-hydroksykwasów i sposób ich zastosowania
WO2008048775A3 (en) Gelled dairy compositions and related methods
BRPI0417672A (pt) processos para produzir composições de vìrus estáveis em armazenamento, composições de vìrus e imunogênicas
BR0307518A (pt) Composição farmacêutica
ATE539769T1 (de) Stabile pharmazeutische zusammensetzungen mit carvedilol
WO2007017895A3 (en) Stabilized oral pharmaceutical compositions of cephalosporins
MD3905G2 (ro) Remediu medicamentos cu acţiune prelungită sub formă de gel pentru tratamentul afecţiunilor parodonţiului (variante)
ATE479426T1 (de) Vorkompaktierte calciumhaltige zusammensetzungen
WO2007022366B1 (en) Rosuvastatin calcium with a low salt by-product content
GB2437903B (en) Lubricating composition
WO2007107328A8 (en) Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue
ZA200805598B (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
KR101985745B1 (ko) 설탕과 기능성 발효액을 이용한 필오프형 마스크팩
WO2008084676A1 (ja) 多孔性乾燥マトリックスの医薬組成物
WO2008030512A3 (en) Polystyrene sulfonate polymer tablets, their preparation and use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08752427

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08752427

Country of ref document: EP

Kind code of ref document: A1